The clinical application and laboratory management of molecular genetic diagnosis in children’s hospital

Abstract

Background: Molecular diagnostic technology is the foundation of precision medicine, which has the advantages of good specificity, high sensitivity, strong targeting, rapiddiagnosis, etc. It has a wide range of applications in the field of pediatrics. However, molecular diagnostic technology is characterized by complicated experimental operation, high difficulty in data analysis and interpretation, in consistent standards among laboratories, and difficult standardization of technical processes. Enhancing the application value of molecular diagnostic technology in pediatrics and promoting the high-quality development of the discipline requires careful consideration by relevant management and professionals.

Methods: This study firstly outlines the development history of molecular diagnostic technology. Then, it analyzes the application of molecular diagnostic technology in the field of pediatrics. Finally, it explores the countermeasures for the management of molecular diagnostic laboratories.

Results: This study highlights the importance of molecular diagnostic technology in providing information and decision-making basis for disease prevention, prediction, diagnosis, treatment and regression. It has a wide range of applications in the molecular diagnosis of pediatric hereditary diseases, malignant tumors and infectious diseases. In addition, the countermeasures for the management of molecular diagnostic laboratories are proposed from the five aspects of laboratory, personnel team construction, standardized management, multidisciplinary cross-discipline, research and translation, safety managementand ethical supervision, and management upgrading and modernization.

Conclusions: Molecular diagnostic technology, as the basis of precision medicine, has become one of the important frontier fields in the development of contemporary pediatric medicine. Enhanced laboratory capacity in molecular diagnostic techniques can improve outcomes in the prevention, prediction, diagnosis, treatment, prognosis and research of pediatricdiseases, and lay the groundwork for child healthcare.

Keywords

clinical application / laboratory management / molecular diagnostic technology / paediatrics

References

[1] BiswasB. Clinical performance evaluation of molecular diagnostic tests. J Mol Diagn. 2016;18(6):803-812.

[2] YingBW. Advances of molecular diagnostic techniques application in clinical diagnosis. J Sichuan Univ Med Sci Ed. 2016;47(6):908-915.

[3] GradaA, Weinbrecht K. Next-generation sequencing: methodology and application. J Invest Dermatol. 2013;133(8):e11.

[4] KircherM, KelsoJ. High-throughput DNA sequencing—concepts and limitations. Bioessays. 2010;32(6):524-536.

[5] GoswamiRS, HaradaS. An overview of molecular genetic diagnosis techniques. Curr Protoc Hum Genet. 2020;105(1):e97.

[6] BrennanML, Schrijver I. Cystic fibrosis: a review of associated phenotypes, use of molecular diagnostic approaches, genetic characteristics, progress, and dilemmas. J Mol Diagn. 2016;18(1):3-14.

[7] FrancescattoL, Katsanis N. Newborn screening and the era of medical genomics[C]Seminars in perinatology. WB Saunders; 2015:617-622.

[8] SzczałubaK, Śmigiel R. Novel cytogenetic and molecular techniques in the diagnosis of congenital anomalies in newborns. Dev Period Med. 2015;19(4):432-440.

[9] XuefanG, Lianshu H, YongguoY. Current status and prospects of screening for newborn hereditary metaboolic disease. J Rare Dis. 2022;1(01):13-19.

[10] LianshuH. Genetic screening techniques and diseases for neonatal genetic diseases. J Zhejiang Univ Med Sci Ed. 2021;50(04):429-435.

[11] HuiliL, HangY, YuanM, et al. Exploration of the verification process for the analytic performance of the quantitative project of molecular diagnosis. Int J Lab Med. 2015;36(16):2360-2362.

[12] LiuQ, JinX, ChengJ, et al. Advances in the application of molecular diagnostic techniques for the detection of infectious disease pathogens. Molec Med Rep. 2023;27(5):1-14.

[13] WrightCF, FitzPatrick DR, FirthHV. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018;19(5):253-268.

[14] MessacarK, ParkerSK, ToddJK, et al. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol. 2017;55(3):715-723.

[15] YanagiharaK. The role of molecular diagnosis in acute respiratory tract infection. Respir Investig. 2019;57(6):511.

[16] LeGolvanMP, Taliano RJ, ResnickMB. Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach. Human Pathol. 2012;43(8):1157-1168.

[17] OzretićL, Heukamp LC, OdenthalM, et al. The role of molecular diagnostics in cancer diagnosis and treatment. Oncol Res Treat. 2012;35(Suppl. 1):8-12.

[18] PosteG. Molecular diagnostics: a powerful new component of the healthcare value chain. Expert Rev Mol Diagn. 2001;1(1):1-5.

[19] WantongL, MeiT, FuyuL, et al. Advances of clinical applications of molecular diagnostic techniques. Lett Biotechnol. 2020;31(02):240-250.

[20] MeiyuS, ShizheT, TingliangX, et al. Research progress on the application of molecular biology in hematological diseases. Prog Mod Biomed. 2020;20(04):797-800.

[21] BingxiongF, XiquanW, YanhongBA, et al. Application and challenge of molecular diagnostics in laboratory medicine. Exp Lab Med. 2014;32(06):700-702.

[22] JianxinLV. Application prospects of molecular diagnostics in laboratory medicine. Chin J Lab Med. 2005;02:14-16.

[23] SaikiR, ScharfS, FaloonaF, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350-1354.

[24] SangerF, Nicklen S, CoulsonAR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74(12):5463-5467.

[25] IyoshiKB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987;155:335-350.

[26] YasukawK, Yanagihara I, FujiwaraS. Alteration of enzymes and their application to nucleic acid amplification (review). Int J Mol Med. 2020;46(5):1633-1643.

[27] KoltaiH, Weingarten-Baror C. Specificity of DNA microarray hybridization: characterization, effectors and approaches for data correction. Nucl Acids Res. 2008;36(7):2395-2405.

[28] MillerDT, AdamMP, AradhyaS, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749-764.

[29] HochstenbachR, van Binsbergen E, EngelenJ, et al. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet. 2009;52(4):161-169.

[30] QingC. The clinical application value and health economics study of molecular diagnostics in children with infectious diseases. China Med News. 2021;36(1):21-21.

[31] RossettiS, Strmecki L, GambleV, et al. Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet. 2001;68(1):46-63.

[32] ShoemakerDD, SchadtEE, ArmourCD, et al. Experimental annotation of the human genome using microarray technology. Nature. 2001;409(6822):922-927.

[33] ZhengZ. The application of molecular biological technique in laboratory medicine. Chin J Lab Med. 2003;26:735736.

[34] MackayIM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect. 2004;10(3):190-212.

[35] MarkoulatosP, Siafakas N, MoncanyM. Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal. 2002;16(1):47-51.

[36] HanAJ, XiongM. Gene chip technology and its advances in medical science. Zhongguo yi xue ke xue Yuan xue bao. Acta Acad Med Sin. 2001;23(5):528-531.

[37] YoheS, Thyagarajan B. Review of clinical next-generation sequencing. Arch Path Lab Med. 2017;141(11):1544-1557.

[38] AthanasopoulouK, BotiMA, AdamopoulosPG, et al. Third-generation sequencing: the spearhead towards the radical transformation of modern genomics. Life. 2022;12(1):30.

[39] XiaoT, ZhouW. The third generation sequencing: the advanced approach to genetic diseases. Transl Pediatr. 2020;9(2):163.

[40] WongLJC. Challenges of bringing next generation sequencing technologies to clinical molecular diagnostic laboratories. Neurotherapeutics. 2013;10(2):262-272.

[41] HuaB, Yongqing T, HongyunZ. New progress in clinical application of molecular diagnosis of genetic diseases. Chin J Microcirc. 2022;32(01):65-70.

[42] DeplanoA, De Mendonca R, De RyckR, et al. External quality assessment of molecular typing of Staphylococcus aureus isolates by a network of laboratories. J Clin Microbiol. 2006;44(9):3236-3244.

[43] Abou TayounAN, KrockB, SpinnerNB. Sequencing-based diagnostics for pediatric genetic diseases: progress and potential. Expert Rev Mol Diagn. 2016;16(9):987-999.

[44] TanY, WeiG, ProcopGW, Persing DH. Molecular diagnostics of infectious diseases. Clin Chem. 1997;43(11):2021-2038.

[45] ZhiyuanW, ChenZ, MingG. Evolutions in half a century: the course of change and development of current molecular diagnostics techniques. Lab Med. 2014;29(03):202-208.

[46] WeltiM, JatonK, AltweggM, et al. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis. 2003;45(2):85-95.

[47] GreubG, LepidiH, RoveryC, et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med. 2005;118(3):230-238.

[48] CorlessCE, GuiverM, BorrowR, et al. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol. 2001;39(4):1553-1558.

[49] WangX, Theodore MJ, MairR, et al. Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens. J Clin Microbiol. 2012;50(3):702-708.

[50] JatonK, BilleJ, GreubG. A novel real-time PCR to detect Chlamydia trachomatis in first-void urine or genital swabs. J Med Microbiol. 2006;55(12):1667-1674.

[51] MahonyJB, Petrich A, SmiejaM. Molecular diagnosis of respiratory virus infections. Crit Rev Clin Lab Sci. 2011;48(5-6):217-249.

[52] SchiblerM, YerlyS, VieilleG, et al. Critical analysis of rhinovirus RNA load quantification by real-time reverse transcription-PCR. J Clin Microbiol. 2012;50(9):2868-2872.

[53] AramburoA, van Schaik S, LouieJ, et al. Role of real-time reverse transcription polymerase chain reaction for detection of respiratory viruses in critically ill children with respiratory disease: is it time for a change in algorithm. Pediatr Crit Care Med. 2011;12(4):e160-e165.

[54] GiulieriS, Morisod B, EdneyT, et al. Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows. Clin Infect Dis. 2011;52(4):488-491.

[55] GourietF, LevyPY, CasaltaJP, et al. Etiology of pericarditis in a prospective cohort of 1162 cases. Am J Med. 2015;128(7). e1-784.e8.

[56] DeverkaPA, HagaSB. Comparative effectiveness research and demonstrating clinical utility for molecular diagnostic tests. Clin Chem. 2015;61(1):142-144.

[57] WeichertW. Molecular diagnostics–Quo vadis? Der Pathologe. 2013;34:230-231.

[58] MiyachiH. Advances in biotechnologies for molecular diagnostics. Japan J Clin Med. 2010;68:205-212.

[59] Shenzhen Patent Association. The development pattern and trend of global molecular diagnostics industry. 2020. [EB/OL]. (2020-02-21). Accessed April 20, 2023. https://www.szpa.org/wap/shownews-353.html

[60] NiuL, JianW. Molecular diagnosis of genetic disease in the era of precision medicine. J Diagn Concepts Practice. 2018;17(2):136-140.

[61] KohAL, JamuarSS. Therapeutics in paediatric genetic diseases: current and future landscape. Singapore Med J. 2023;64(1):7-16.

[62] BickD, JonesM, TaylorSL, et al. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. J Med Genet. 2019;56(12):783-791.

[63] BoycottKM, DymentDA, SawyerSL, et al. Identification of genes for childhood heritable diseases. Annu Rev Med. 2014;65:19-31.

[64] World Health Organization. World health statistics 2018: monitoring health for the SDGs, sustainable development goals[M]. World Health Organization; 2018.

[65] The Central People's Government of the People's Republic of China. Report on the prevention and treatment of birth defects in China(2012)[R].The Central People's Government of the People's Republic of China; 2012:1.

[66] MarshallDA, Benchimol EI, MacKenzieA, et al. Direct health-care costs for children diagnosed with genetic diseases are significantly higher than for children with other chronic diseases. Genet Med. 2019;21(5):1049-1057.

[67] DyeDE, Brameld KJ, MaxwellS, et al. The impact of single gene and chromosomal disorders on hospital admissions of children and adolescents: a population-based study. Public Health Genom. 2011;14(3):153-161.

[68] RodeJ. Rare diseases: understanding this public health priority. EURORDIS; 2005;5(1):3.

[69] YoonPW, OlneyRS, KhouryMJ, et al. Contribution of birth defects and genetic diseases to pediatric hospitalizations: a population-based study. Arch Pediatr Adolesc Med. 1997;151(11):1096-1103.

[70] YanrongW, Runming J. Current status in diagnosis and therapy of common genetic diseases in children disease. J New Med. 2008(03):198-200.

[71] FengP. Rare diseases need to construct a multi-level medical service and security system. China Med Herald. 2022;19(07):1-6.

[72] JinyueH, BiliZ, WeiL. Clinical diagnostic techniques for rare genetic diseases in children: current status, advances, and thoughts. Chin J Contemp Pediatr. 2023;25(3):308-314.

[73] BamshadMJ, Nickerson DA, ChongJX. Mendelian gene discovery: fast and furious with no end in sight. Am J Hum Genet. 2019;105(3):448-455.

[74] HuX, LiN, XuY, et al. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience. Genet Med. 2018;20(9):1045-1053.

[75] WangY, XuY, ZhouC, et al. Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy. Nat Med. 2024:1-11.

[76] ZhengR, PengX, ZengH, et al. Incidence, mortality and survival of childhood cancer in China during 2000–2010 period: a population-based study. Cancer Lett. 2015;363(2):176-180.

[77] NiX, LiZ, LiX, et al. Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study. Lancet. 2022;400(10357):1020-1032.

[78] MaX, LiuY, LiuY, et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature. 2018;555(7696):371-376.

[79] KattnerP, Strobel H, KhoshnevisN, et al. Compare and contrast: pediatric cancer versus adult malignancies. Cancer Metastasis Rev. 2019;38(4):673-682.

[80] YifanC, RunzhiL, JinhuW, et al. Advances in targeted therapies for pediatric tumors. Prog Pharm Sci. 2022;46(12):922-936.

[81] Van PaemelR, VlugR, De PreterK, et al. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review. Eur J Pediatr. 2020;179(2):191-202.

[82] LiB, BradySW, MaX, et al. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Blood. 2020;135(1):41-55.

[83] SalzerE, HutterC. Therapy concepts in the context of precision medicine for pediatric malignancies—children are not adults. Memo. 2021;14(3):273-277.

[84] QingC, Qiaozhen Z, YueZ, et al. Diagnostic value and health economic evaluation of nucleic acid molecular detection technology in children with infectious diseases. Chin J Appl Clin Pediatr. 2020;35(22):1689-1693.

[85] GanC, HuJ, CaoQ, et al. Rapid identification of pathogens involved in pediatric osteoarticular infections by multiplex PCR. Ann Transl Med. 2020;8(5):203.

[86] QiongLI. Application and challenge of molecular diagnostics in laboratory medicine. China Contin Med Educ. 2018;10(34):61-62.

[87] WeilinF, YangL. Application of molecular diagnosis in hospital infection. Chin J Nosocomiol. 2009;19(14):1771-1775.

[88] LiX, CaoZ, ChenL, et al. Consideration on construction and development of University Engineering Training Center. Proc Eng. 2011;15:4194-4199.

[89] YingL, Dingqian G, FengH, et al. Exploration on the construction of university laboratory management team. Sci Consult. 2022(09):4-6.

[90] XinS, SifanJ. Reflection on experimental technical team construction in university in new era. Chem Manag. 2022(25):5-7.

[91] YonghongL. Research on the problems and strategies of laboratory management in universities. Ke Ji Feng. 2022(24):133-135.

[92] JunTian, ZhibinYao, QiangWang, et al. Thinking on the construction of experimental technicians in colleges and universities. Lab Sci. 2022;25(04):144-147.

[93] NangLI, MeiwoKU, JuanyaLI, et al. Research on the development dilemma and countermeasures of the experimental technicians in colleges and universities. Lab Sci. 2022;25(03):165-168.

[94] YagangL, QiyingZ, DianW. Thoughts on strengthening laboratory management in colleges and universities. Res Expl Lab. 2020;39(05):244-246.

[95] GuangtiL, Shufeng L, LiY, et al. Research on the existing problems and countermeasures of experimental technical team in university. Lab Sci. 2017;20(03):171-174.

[96] LiLI, JingQI. Current situation, problems and countermeasures of the work of experimental technicians in colleges and universities. Agri Henan. 2015(12):9-11.

[97] YangJ, Shaoying Z, BozhongY, et al. Current situation of cultivation of young scholars and suggestions on improvement—a case study of Chinese academy of sciences. Bull Chin Acad Sci. 2017;32(06):641-648.

[98] McClellandDC, Atkinson JW, ClarkRA, LowellEL. The Achievement Motive. Appleton-Century-Crofts; 1953.

[99] TingW, YuanM, PeichenL, et al. Exploration of Multidisciplinary integration in the undergraduate teaching of medical laboratory science. Medical Education Research and Practice. 2022;30(2):153-157.

[100] DaguangQI. Standardization construction of university laboratory quality management system. Popular Standard. 2023(09):17-19.

[101] FeiLV. Research on standardization construction and quality management of university laboratories. Popular Standard. 2022(03):150-152.

[102] JianX, YangZ, JianchaoS, et al. Research on the development of laboratory medicine and talent cultivation. Chin J Clin Lab Manage. 2017;5(03):149-151.

[103] BiqingY, HuiG. Opportunities and challenges faced by modern hospital clinical laboratory management. Clin Res Pract. 2016;1(11):177.

[104] QiongjianH. For clinical laboratory development and promotion with translational medicine concept. Transl Med J. 2014;3(02):118-121.

[105] PengXU. Problems and countermeasures of university laboratory safety management. Western China Qual Educ. 2022;8(22):178-181.

[106] MinfangY. Research on the problems and countermeasures of construction of laboratory safety management standard. Popular Standard. 2022(22):85-87.

[107] YuyinL, Xiaoliang D, KunL, et al. Status quo of open laboratory safety management at institutions of higher learning and corresponding improvement strategies. Basic Med Educ. 2022;24(09):691-695.

[108] HanzhenX, HuiC, JinshanZ, et al. Ethical issues and countermeasures for clinical gene diagnosis. Chin Med Ethics. 2015;28(04):652-654.

[109] CaulfieldT, McGuire AL, ChoM, et al. Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol. 2008;6(3):e73.

[110] LevensellerBL, Soucier DJ, MillerVA, et al. Stakeholders' opinions on the implementation of pediatric whole exome sequencing: implications for informed consent. J Genet Couns. 2014;23:552-565.

[111] McGuireAL, Caulfield T, ChoMK. Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet. 2008;9(2):152-156.

[112] OrmondKE. From genetic counseling to “genomic counseling”. Mol Genet Genomic Med. 2013;1(4):189.

[113] TaberK, Dickinson BD, WilsonM. The promise and challenges of next-generation genome sequencing for clinical care. JAMA Intern Med. 2014;174(2):275-280.

[114] TaborHK, Berkman BE, HullSC, et al. Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. Am J Med Genet A. 2011;155(12):2916-2924.

[115] MabileL, Dalgleish R, ThorissonGA, et al. Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience. 2013;2(1):2047-217X-2.

[116] ChenB, GagnonMB, ShahangianS, et al. Good laboratory practices for molecular genetic testing for heritable diseases and conditions. Morb Mortal Weekly Rep. 2009;58(6):1.

[117] AiyaoM, AiluM, HuijunW, et al. Whole exome sequencing: a new idea for diagnosis of childhood diseases. Chin J Evid Based Pediatr. 2015;10(01):4-18.

[118] YuanhongGE. Research on Personal Genome Data Management and Visualization Techniques. Harbin Institute of Technology; 2011.

[119] YitingLI. Ethical principles of clinical diagnosis and treatment of children's diseases. Chin Med Ethics. 1997;(05):39-41.

[120] DiweiXU, ZhuL, ZhipingMA, et al. Construction of Science and Technology Platform Innovation Management of Science and Technology Resources. South China University of Technology Press. 2021;202105.223.

[121] LinyingZ, YanS, LiX, et al. The research and market development situation of molecular diagnostics. Biotechnol Business. 2018;(02): 6-13.

[122] China National Accreditation Service for Conformity Assessment. Guidance on the Application of Accreditation Criteria for the Medical Laboratory Quality and Competence in the Field of Molecular Diagnostics (CNAS-CL02-A009) [EB/OL]. (2018-03-01). Accessed April 20, 2023. https://www.cnas.org.cn/rkgf/sysrk/rkyyzz/2018/03/889110.shtml

RIGHTS & PERMISSIONS

2024 2024 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.